1. Home
  2. SRI vs MIST Comparison

SRI vs MIST Comparison

Compare SRI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$7.39

Market Cap

161.7M

ML Signal

HOLD

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

HOLD

Current Price

$1.16

Market Cap

176.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
MIST
Founded
1965
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
176.3M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
SRI
MIST
Price
$7.39
$1.16
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$16.00
$8.00
AVG Volume (30 Days)
306.3K
1.2M
Earning Date
05-01-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,444,000.00
N/A
Revenue This Year
N/A
$2,915.14
Revenue Next Year
$4.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.46
N/A
52 Week Low
$4.60
$1.00
52 Week High
$9.71
$3.06

Technical Indicators

Market Signals
Indicator
SRI
MIST
Relative Strength Index (RSI) 51.90 36.21
Support Level $7.26 $1.00
Resistance Level $7.48 $1.42
Average True Range (ATR) 0.30 0.06
MACD 0.01 -0.00
Stochastic Oscillator 67.95 5.71

Price Performance

Historical Comparison
SRI
MIST

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: